1193883

Wells Pharma of Houston LLC — FEI 3016710931

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 14, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Houston, TX (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
127421 CFR 211.68(a)Calibration/Inspection/Checking not done